Sanofi, a global and diversified healthcare leader, reports results for
the third-quarter of 2013. Jérôme Contamine, Chief Financial Officer of
Sanofi, comments on results and outlook.
Watch video interview and read transcript:
http://www.eurobusinessmedia.com/Sanofi-Q3-2013-Interview-with-CFO-Jerome-Contamine?utm_source=ceo-direct&utm_medium=bwl
Topics covered in the interview include:
- Q3 2013 Results
- Diabetes
- Vaccines
- Emerging Markets
- Consumer Healthcare
- Genzyme
- Animal Health
- Alirocumab
- Guidance
About Sanofi
Sanofi, an integrated global healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients’ needs. Sanofi has
core strengths in the field of healthcare with seven growth platforms:
diabetes solutions, human vaccines, innovative drugs, consumer
healthcare, emerging markets, animal health and the new Genzyme. Sanofi
is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Company website: www.sanofi.com
Copyright Business Wire 2013